Technology transfer (TT) is the systematic transfer of manufacturing knowledge, processes, and analytical methods from one facility (sending unit) to another (receiving unit). For peptide APIs, TT must address the unique challenges of SPPS, cleavage/deprotection, purification, and lyophilization, each with process-specific nuances.
| Phase | Activities | Duration | Key Deliverable |
|---|
| 1. Planning | TT plan, gap assessment, resource allocation | 2–4 weeks | TT Master Plan |
| 2. Knowledge Transfer | Training, documentation, data sharing | 4–8 weeks | Knowledge package |
| 3. Process Transfer | Equipment qualification, process setup | 4–12 weeks | Process qualification |
| 4. Validation | PPQ, analytical method transfer | 4–8 weeks | Validation report |
| 5. Commercial Production | Ongoing manufacturing | Ongoing | Commercial supply |
| Guideline | Topic | Application |
|---|
| ICH Q10 | Pharmaceutical Quality System | Lifecycle management |
| ICH Q7 | GMP for APIs | Manufacturing standards |
| ICH Q11 | Development and Manufacture of Drug Substances | CMC requirements |
| FDA Guidance | Process Validation | Validation approach |
| EU GMP Annex 15 | Qualification and Validation | EU qualification requirements |
| WHO TRS 986 Annex 2 | GMP for Peptide APIs | WHO requirements |
| Document | Contents | Format |
|---|
| Drug Master File (DMF) | Complete CMC data | Regulatory submission |
| Batch records | Manufacturing instructions | Controlled document |
| SOPs | All critical procedures | Controlled document |
| Analytical methods | Complete validated methods | Method package |
| Specifications | Acceptance criteria | Controlled document |
| Stability data | Stability studies | Report |
| Deviation history | Known issues and resolutions | Summary report |
| Process validation | PPQ reports | Report |
| Cleaning validation | Cleaning procedures and validation | Report |
| Process Step | Knowledge to Transfer |
|---|
| Resin selection | Resin type, loading capacity, vendor |
| Amino acid activation | Activating agent, base, solvent, temperature |
| Coupling strategy | Standard, double, pseudo, microwave |
| Fmoc deprotection | Base, solvent, time, monitoring |
| Cleavage cocktail | TFA/scavenger ratios, time, temperature |
| Precipitation | Precipitant, volume, temperature, centrifugation |
| HPLC purification | Column, mobile phase, gradient, flow rate, temperature |
| Lyophilization | Cycle parameters, shelf temperature, vacuum |
| Analytical methods | HPLC, MS, AAA, KF, LAL, etc. |
| Equipment | Qualification Status | Transferability |
|---|
| Peptide synthesizer | PPQ completed | High |
| HPLC system | PPQ completed | High |
| Lyophilizer | PPQ completed | High |
| Analytical instruments | IQ/OQ/PQ completed | High |
| WFI system | PPQ completed | Facility-specific |
| Requirement | Standard | Verification |
|---|
| Equipment qualification | IQ/OQ/PQ complete | Qualification reports |
| Utility qualification | WFI, clean steam, gases | Qualification reports |
| Environmental qualification | ISO classification | Environmental monitoring |
| Computer system validation | 21 CFR Part 11 (if applicable) | CSV reports |
| Instrument calibration | Per SOP | Calibration certificates |
| Parameter | Sending Unit | Receiving Unit | Match? |
|---|
| Synthesizer type | [Vendor/Model] | [Vendor/Model] | Y/N |
| Synthesizer capacity | [kg resin] | [kg resin] | Y/N |
| HPLC column dimensions | [dimensions] | [dimensions] | Y/N |
| HPLC pump flow rate | [L/min] | [L/min] | Y/N |
| Lyophilizer shelf area | [m²] | [m²] | Y/N |
| Lyophilizer condenser | [L] | [L] | Y/N |
| Analytical HPLC | [vendor/model] | [vendor/model] | Y/N |
| Step | Activity | Acceptance Criterion |
|---|
| 1 | Method validation at receiving unit | All parameters meet criteria |
| 2 | Co-validation or transfer study | RSD ≤2% (intermediate) |
| 3 | Parallel testing | Results within ±2% |
| 4 | Method qualification report | Approved by QA |
| Parameter | Sending Unit | Receiving Unit | Acceptance |
|---|
| Specificity | Confirmed | Confirmed | No interference |
| Linearity | r² ≥0.999 | r² ≥0.999 | Equivalent |
| Accuracy | 98–102% | 98–102% | Within 2% |
| Precision (RSD) | ≤2% | ≤2% | Equivalent |
| LOQ | ≤0.1% | ≤0.1% | Equivalent |
| Intermediate precision | ≤3% | ≤3% | Within 1% |
| Sample Type | n | Acceptance Criterion |
|---|
| Reference standard | 6 | RSD ≤2% |
| Production batches | 6 | Individual result ±2% |
| Stability samples | 6 | Individual result ±2% |
| Impurity standards | 3 | Individual result ±5% |
| Batch | Scale | Purpose |
|---|
| Laboratory-scale | 10–100 g | Confirm process parameters |
| Pilot-scale | 100 g–1 kg | Scale-up verification |
| PPQ-scale | Full production | Validation |
| Activity | Sending Unit | Receiving Unit |
|---|
| Resin loading | Optimize loading density | Match or optimize |
| Coupling optimization | Documented parameters | Reproduce or optimize |
| Cleavage optimization | Cocktail composition | Reproduce |
| HPLC method transfer | Column, gradient, flow | Transfer and validate |
| Lyophilization transfer | Cycle parameters | Transfer and validate |
| Analytical transfer | All methods | Validate at receiving |
| Risk | Severity | Probability | Mitigation |
|---|
| Equipment mismatch | High | Medium | Equipment qualification, process adaptation |
| Analytical method failure | High | Low | Co-validation, parallel testing |
| Process deviation | High | Medium | Detailed training, pilot batches |
| Regulatory delay | Medium | Medium | Early engagement, gap assessment |
| Knowledge loss | High | Low | Comprehensive knowledge package |
| Personnel inexperience | Medium | High | Training program, hands-on experience |
| Strategy | Implementation |
|---|
| Gap assessment | Comprehensive comparison of equipment and processes |
| Training program | Sending unit training for receiving unit personnel |
| Pilot batches | Minimum 3 batches at receiving unit |
| Parallel testing | Head-to-head comparison of analytical results |
| Regulatory pre-submission | Pre-IND or Type C meeting |
| Contingency planning | Alternative processes, equipment |
| Role | Training Content | Duration |
|---|
| QA Manager | TT plan, validation, regulatory | 40 hours |
| Production Manager | Process transfer, batch records | 40 hours |
| Analytical Manager | Method transfer, validation | 40 hours |
| Operators | Equipment operation, SOPs | 80 hours |
| QC Analysts | Analytical methods | 40 hours |
| Document | Contents |
|---|
| Training plan | Schedule, topics, trainers |
| Training records | Attendance, competency assessment |
| Competency assessment | Written test, practical demonstration |
| Training certificates | Completion documentation |
| Filing | Contents | Timing |
|---|
| Prior Approval Supplement (PAS) | Major changes requiring approval | Before commercial production |
| Changes Being Effected (CBE) | Moderate changes | 30 days before commercial |
| Annual Report | Minor changes | Annual |
| Type C meeting | Pre-submission advice | 6–12 months before commercial |
| Section | Contents |
|---|
| S.1 | General information |
| S.2 | Manufacture |
| S.3 | Characterization |
| S.4 | Control of drug substance |
| S.5 | Reference standards |
| S.6 | Container closure system |
| S.7 | Stability |
| Activity | Frequency | Acceptance |
|---|
| Batch release testing | Every batch | Meets specifications |
| Process capability (Cpk) | Per CQA | Cpk ≥1.33 |
| Stability monitoring | Annual | Meets retest date |
| Environmental monitoring | Continuous | Within limits |
| CAPA tracking | Ongoing | Trending analysis |
| Activity | Frequency |
|---|
| Annual product review | Annual |
| Process capability assessment | Semi-annual |
| SOP review | Annual |
| Equipment maintenance review | Semi-annual |
| Training effectiveness review | Annual |
